While sommarutide is undoubtedly an exciting potential treatment option, there is still a lack of clear clinical data on the mechanism of action of GLP-1 agonists in NASH, such as whether GLP-1 agonists have a direct, independent role in improving NASH, or simply by improving body weight, insulin resistance, and so on
Key Takeaways PRP uses your own blood, spun to concentrate platelets and growth factors, injected into the scalp to stimulate follicles
Stay Hydrated: Ensure sufficient fluid consumption to help handle side reactions and support overall health
Lancet 393 , 20512058 (2019)
Acknowledgements P.B
Tirzepatide, a newer dual-action compound, targets both GLP-1 and GIP receptors, engaging a broader network of metabolic control centers in the brain and gut